8.33
price down icon0.72%   -0.06
after-market Handel nachbörslich: 8.23 -0.10 -1.20%
loading

Zevra Therapeutics Inc Aktie (ZVRA) Neueste Nachrichten

pulisher
04:44 AM

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

04:44 AM
pulisher
Dec 06, 2025

Schroder Investment Management Group Acquires New Position in Zevra Therapeutics, Inc. $ZVRA - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Zevra Therapeutics, Inc. $ZVRA Holdings Boosted by Stonepine Capital Management LLC - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

Zevra Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Dec 04, 2025
pulisher
Dec 04, 2025

How Zevra Therapeutics Inc. stock performs after earningsPortfolio Value Report & Expert Approved Momentum Ideas - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Behavioral Patterns of ZVRA and Institutional Flows - news.stocktradersdaily.com

Dec 03, 2025
pulisher
Dec 03, 2025

Does Zevra Therapeutics’ (ZVRA) Board Turnover Subtly Recast Its Leadership and Capital Allocation Narrative? - simplywall.st

Dec 03, 2025
pulisher
Dec 03, 2025

Why Zevra Therapeutics Inc. stock is favored by top institutionsDollar Strength & Stepwise Entry and Exit Trade Signals - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Legal & General Group Plc Grows Stock Position in Zevra Therapeutics, Inc. $ZVRA - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

Zevra Therapeutics (ZVRA): Evaluating Valuation Following High-Profile Board Appointment and CFO Transition - simplywall.st

Dec 02, 2025
pulisher
Dec 02, 2025

Zevra Therapeutics, Inc. Announces Director and Committee Changes, Effective as of December 2, 2025 - marketscreener.com

Dec 02, 2025
pulisher
Dec 02, 2025

Zevra Therapeutics appoints Alicia Secor to board of directors; announces retirement of Wendy Dixon - marketscreener.com

Dec 02, 2025
pulisher
Dec 02, 2025

Zevra Therapeutics Appoints Alicia Secor to Board - TipRanks

Dec 02, 2025
pulisher
Dec 02, 2025

ZVRA FinancialsIncome Statement - Quiver Quantitative

Dec 02, 2025
pulisher
Dec 02, 2025

Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD - The Manila Times

Dec 02, 2025
pulisher
Dec 02, 2025

Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors, Announces Retirement of Wendy Dixon - Quiver Quantitative

Dec 02, 2025
pulisher
Dec 02, 2025

Zevra Therapeutics Announces Board Changes - TradingView

Dec 02, 2025
pulisher
Dec 02, 2025

Zevra Therapeutics (NasdaqGS: ZVRA) names Alicia Secor to board as Wendy Dixon, PhD, retires - Stock Titan

Dec 02, 2025
pulisher
Dec 02, 2025

How Zevra Therapeutics Inc. (1GDA) stock valuation compares with sectorQuarterly Portfolio Report & Growth Focused Entry Reports - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

How Zevra Therapeutics Inc. (1GDA) stock expands through international marketsGDP Growth & Verified High Yield Trade Plans - Newser

Dec 02, 2025
pulisher
Nov 27, 2025

How institutional buying supports Zevra Therapeutics Inc. stock - moha.gov.vn

Nov 27, 2025
pulisher
Nov 25, 2025

Zevra Therapeutics (ZVRA): Assessing Valuation After CFO Succession News Spurs Fresh Investor Interest - simplywall.st

Nov 25, 2025
pulisher
Nov 22, 2025

(ZVRA) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Nov 22, 2025
pulisher
Nov 21, 2025

Zevra Therapeutics CFO Resignation Announced - The Globe and Mail

Nov 21, 2025
pulisher
Nov 21, 2025

Zevra Therapeutics announces CFO transition - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

Will Zevra Therapeutics Inc. (1GDA) stock issue positive guidanceGlobal Markets & Daily Technical Forecast Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why Zevra Therapeutics Inc. stock could rally in 2025July 2025 Analyst Calls & Safe Entry Point Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Zevra Therapeutics Announces CFO Transition - citybiz

Nov 21, 2025
pulisher
Nov 20, 2025

Zevra Therapeutics (ZVRA) CFO to Step Down, Shares Fall - GuruFocus

Nov 20, 2025
pulisher
Nov 20, 2025

Zevra Therapeutics, Inc. announces CFO transition - marketscreener.com

Nov 20, 2025
pulisher
Nov 20, 2025

[8-K] ZEVRA THERAPEUTICS, INC. Reports Material Event | ZVRA SEC FilingForm 8-K - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Zevra Therapeutics Announces Departure of CFO R. LaDuane Clifton, Effective December 31, 2025 - Quiver Quantitative

Nov 20, 2025
pulisher
Nov 20, 2025

Zevra Therapeutics, Inc. Announces CFO Transition - GlobeNewswire

Nov 20, 2025
pulisher
Nov 20, 2025

Zevra Therapeutics, Inc. Announces Chief Financial Officer R. LaDuane Clifton to Step Down, Effective December 31, 2025 - marketscreener.com

Nov 20, 2025
pulisher
Nov 19, 2025

Visualizing Zevra Therapeutics Inc. stock with heatmapsJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Zevra Therapeutics Inc. (1GDA) stock return to pre crash levelsWeekly Profit Report & Growth Focused Investment Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Does Zevra Therapeutics Inc. (1GDA) stock trade below intrinsic valueEarnings Beat & Safe Entry Zone Identification - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What the charts say about Zevra Therapeutics Inc. todayQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Zevra Therapeutics Inc. (1GDA) stock a top hedge fund pick2025 Sector Review & High Yield Stock Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How sentiment analysis helps forecast Zevra Therapeutics Inc.July 2025 Outlook & Short-Term High Return Strategies - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 17, 2025
pulisher
Nov 16, 2025

Can Zevra Therapeutics Inc. stock beat market expectations this quarterBuy Signal & Technical Pattern Based Signals - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Will Zevra Therapeutics Inc. stock outperform growth indexesJuly 2025 Pullbacks & Pattern Based Trade Signal System - newser.com

Nov 15, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):